Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSPHENYTOIN vs FRUQUINTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSPHENYTOIN vs FRUQUINTINIB: Safety Overview

Metric FOSPHENYTOIN FRUQUINTINIB
Total FAERS Reports 1,378 2,565
Deaths Reported 166 874
Death Rate 12.0% 34.1%
Hospitalizations 646 753
Average Patient Age 37.5 yrs 63.9 yrs
% Female Patients 52.4% 44.4%
FDA Approval Date Aug 5, 1996 Nov 8, 2023
Manufacturer Pfizer Laboratories Div Pfizer Inc Takeda Pharmaceuticals America, Inc.
Route INTRAMUSCULAR ORAL
Marketing Status Prescription Prescription